BMS, Sanofi Can't Shake FCA Suit Over Plavix Marketing

Law360, New York (January 30, 2013, 7:38 PM EST) -- An Illinois federal judge on Wednesday refused to dismiss a Sanofi SA employee’s False Claims Act suit accusing several Sanofi units and Bristol-Myers Squibb Co. of overstating the efficacy of blockbuster blood thinner Plavix, allegedly causing government health care programs to pay for fraudulent prescriptions of the drug.

According to U.S. District Judge David R. Herndon’s order, relator Elisa Dickson had provided enough substance and specificity to meet legal standards for her claims that the drugmakers had engaged in a scheme to falsely market Plavix to doctors...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.